Navigation Links
Pelvic Mesh for Incontinence May Carry Added Risk for Women: FDA
Date:7/13/2011

WEDNESDAY, July 13 (HealthDay News) -- A mesh device used to support the pelvic organs and help ease incontinence in women appears to carry more risks than previously thought, the U.S. Food and Drug Administration announced Wednesday.

In an "updated safety communication warning," the FDA said that surgical placement of the mesh through the vagina to fix a condition known as pelvic organ prolapse may lead to greater risks than other surgical methods, while not providing any greater clinical benefit.

"There are clear risks associated with the transvaginal placement of mesh to treat pelvic organ prolapse," Dr. William Maisel, deputy director and chief scientist of the FDA's Center for Devices and Radiological Health, said in an agency news release. "The FDA is asking surgeons to carefully consider all other treatment options and to make sure that their patients are fully informed of potential complications from surgical mesh. Mesh is a permanent implant -- complete removal may not be possible and may not result in complete resolution of complications."

Pelvic organ prolapse involves a weakening or stretching of internal structures that support organs such as the bladder, bowel and uterus. These organs then drop to below their normal position and bulge (prolapse) into the vagina. This can lead to pelvic pain and disruption of sexual, urinary or defecatory function, the FDA explained.

There are numerous means of correcting the problem, such as surgeries carried out through the abdomen or the vagina using traditional stitches, or using the mesh to help improve internal support of the pelvic organs.

However, the FDA says that between 2008 and 2010, the agency received more than 1,500 "adverse event" reports regarding patients who had undergone the mesh procedure -- five times as many as were reported between 2005 and 2007. Some of the most commonly cited problems included pain, infection, bleeding, pain during sexual intercourse and urinary problems. Reports were also found of the mesh becoming exposed or protruding from vaginal tissue, or organ perforation from tools used during the surgical placement of the mesh.

More than 100,000 mesh procedures for the treatment of pelvic organ prolapse, 75,000 of which were transvaginal, were carried out in 2010 in the United States, the FDA stated.

The FDA also looked over data from 1996 to 2010 pitting mesh surgeries against non-mesh surgeries and found that the former seemed to carry heightened risks but no greater clinical benefit.

Based on their findings, the agency is urging health-care providers to remember that pelvic organ prolapse can be successfully treated without the use of mesh, with potentially fewer complications or adverse events. The agency urges patients who have had the procedure to check in regularly with their doctors, especially if pain or bleeding develops.

In a statement, the American College of Obstetricians & Gynecologists (ACOG) said it "applauds" the agency move. "The College shares the FDAs concerns and encourages patients and physicians to review the FDA's White Paper that describes, in detail, the health risks associated with the surgical mesh products when used to treat pelvic organ prolapse," the ACOG said.

The FDA plans to convene an independent panel of experts to meet and discuss the issue in early September. "Input from the clinicians, manufacturers and other experts will help the FDA better understand the safety and effectiveness of surgical mesh for [pelvic organ prolapse and stress urinary incontinence] repair, including any changes that would improve our oversight," Maisel said.

More information

Find out more about pelvic organ prolapse at the University of Michigan Health System.

-- HealthDay Staff

SOURCE: U.S. Food and Drug Administration, news release, July 13, 2011, and statement, American College of Obstetricians & Gynecologists


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pelvic widening continues throughout a persons lifetime, UNC study
2. Study says eliminate pelvic imaging to reduce radiation for the detection of venous thromboembolism
3. Pelvic-repair device developed by UT Southwestern surgeons enables minimally invasive trauma surgery
4. Kids With Cerebral Palsy May Have Asymmetric Pelvic Bones
5. Hopkins Childrens study finds some patients with cerebral palsy have asymmetric pelvic bones
6. New educational DVD improves female pelvic exam instruction
7. Women & Infants launches Rhode Island Network for Pelvic Floor Disorders
8. Earlier Diagnosis Might Cut Cost of Teen Pelvic Disease
9. Study Gauges Best Treatments for Chronic Pelvic Pain in Men
10. Study finds high rate of c-sections after pelvic fractures
11. Cancer Drug Safe for Late-Stage Pelvic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pelvic Mesh for Incontinence May Carry Added Risk for Women: FDA
(Date:2/20/2017)... PA (PRWEB) , ... February 20, 2017 , ... ... collaborating to help health care providers better manage patient health risks, foster behavior change ... medication video library in the world, will present a demonstration of its video capability ...
(Date:2/20/2017)... ... February 20, 2017 , ... ReportingMD, a Population Health Software Company, is pleased to announce ... The new location will triple the size of the previous location while bringing life ... Sunapee, NH. , “We are excited to expand our footprint to better serve ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... care providers and health plan partners, announced during the 2017 Annual HIMSS ... enhancing care coordination for diabetic patients and integrating eye care into mainstream ...
(Date:2/19/2017)... , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 glitch ... Glitch users can easily reveal any logo with a glitch reveal in just a few ... over the style and animation of each preset. Use these presets to add a uniquely ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... of disruptive innovation in the industry, according to the recent NEJM Catalyst Insights ... on surveys of the NEJM Catalyst Insights Council, a qualified group of U.S. ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Conn. , Feb. 17, 2017 Arvinas ... of drugs based on protein degradation, today announced the ... receptor (AR) PROTAC during a poster session at the ... (ASCO GU) in Orlando, FL. ... to validate our platform and the potential of PROTACs ...
(Date:2/17/2017)... and Markets has announced the addition of the "Drug-Eluting Stents - ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... , Feb. 17, 2017 ... health offerings at the  2017 HIMSS ... PHG,AEX: PHIA), a global leader ... broad range of population health ... health solutions, fully integrated in a highly ...
Breaking Medicine Technology: